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A B S T R A C T
Inflammatory myofibroblastic tumor (IMT) is a pseudosarcomatous lesion occurring in soft tissue and organs. It is
known under a wide number of terms, such as inflammatory pseudotumor, plasma cell granuloma, pseudosarcomatous
myofibroblastic proliferation. IMT is most commonly located in the lung, while laryngeal location is rarely described.
Due to its’ biology it can be misdiagnosed as a malignant tumor. We present a case of IMT of larynx, recognized in time
and treated with laser ablation. Our case demonstrates the importance of timely IMT recognition in order to avoid
overtreatment. This diagnosis should also alert clinicians to close follow-up of these patients.
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Introduction
Inflammatory myofibroblastic tumor (IMT) is a pseu-
dosarcomatous lesion of uncertain origin occurring in
soft tissue and organs. It is known under a wide number
of terms, such as inflammatory pseudotumor, plasma cell
granuloma, pseudosarcomatous myofibroblastic prolifer-
ation etc., partly reflecting its spectrum of appearance1.
It is most commonly located in the lung. In the head and
neck region it usually occupies periorbital and orbital
soft tissue. Location of IMT in larynx is very rare2–5, with
39 cases reported so far6. It is more common in male,
with male to female ratio of 1.45:1, and the mean age at
presentation is 43 years6. Because of infiltrative local
growth, potential for recurrence, vascular invasion and
distal metastasis it is regarded by some authors as a neo-
plastic process7.
The etiology and pathogenesis of this lesion still re-
mains unresolved, although infection, trauma and irradi-
ation are possible etiologic factors3,8.
We present a case of a male patient with laryngeal
IMT.
Case Report
A 67-year-old male presented with a several weeks
history of persistent hoarseness. He had no history of
trauma or previous operation and was a non smoker. The
physical examination was normal and no cervical lym-
phadenopathy was detected. Fiberoptic laryngoscopy de-
monstrated a tumorous mass in anterior glotic region. A
biopsy was performed and revealed granulation tissue.
After few weeks of antibiotic therapy further growth of
the lesion was observed. On repeated biopsy pyogenic
granuloma was diagnosed. Six weeks later, because of the
progression of the lesion, new laryngoscopic examination
showed a submucosal ulcerated nodular mass projecting
from the anterior commissure into the subglottis, par-
tially obstructing the lumen. Microlaryngoscopic biopsy
followed by CO2 laser ablation was performed and the
specimens were sent for histological examination. The
material consisted of several fragments up to 1.2 cm in
the largest diameter. Histologically, they were mostly
composed of spindle-shaped cells with long to plump nu-
clei of fibroblastic appearance displaying slight polymor-
phism (Figure 1a). Mitoses were present up to 4 per 10
high-power fields (HPF). Occasionally, especially toward
the surface of the specimen, the nuclei displayed a more
square, epitheloid shape. The surface epithelium was
mostly eroded, covered by fibrin and cellular debris. Un-
derneath was prominent granulation tissue with endo-
thelial cells displaying pleomorphism (Figure 1b). Dif-
fuse abundant inflammatory infiltrate was present throu-
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ghout the material, composed mainly of granulocytes in
the surface area and becoming more mononuclear to-
ward the deeper regions. There was no necrosis. Immu-
nohistochemically, most of the fibroblastic cells were
vimentin and smooth muscle actin (SMA) positive (Fig-
ure 1c), while the epitheloid and pleomorphic cells also
displayed CD31 (Figure 1d) and CD68 positivity. All tu-
mor cells were negative for EMA, S-100, CK, desmin and
ALK-1. Our final diagnosis was inflammatory myofibro-
blastic tumor, but because of the laser ablation procedure
margins were not particularly analyzed. Additional treat-
ment was not applied. Two years after the final diagnosis
the patient is still alive, with recurrence of the tumor and
progression to trachea.
Discussion
Because of its’ biological behavior IMT can be re-
garded as a malignant tumor. The neoplastic theory has
been supported by occasional recurrence and even meta-
static potential of IMT (not reported for laryngeal local-
ization). In addition, aneuploidy, clonality, chromosomal
rearrangement (2p23), expression of ALK1 and p80 have
also been demonstrated9–13. According to the Volker et
al., only 2 out of 20 laryngeal IMT demonstrated ALK-1
positivity, which does not have any real prognostic signif-
icance in IMT13–16. The concept of IMT being an exuber-
ant post inflammatory reaction is supported by its post-
traumatic/postsurgery appearance as well as the success-
ful application of anti-inflammatory drugs (both steroidal
and nonsteroidal) in therapy17,18.
The usual leading symptom is hoarseness; however
dyspnea, stridor, dysphasia and dysphonia may also oc-
cur. Most commonly the lesions are flashy and firm in ap-
pearance, with polypoidal, pedunculated or nodular gro-
wth involving the vocal cords. Wenig et al. in their initial
paper, where they presented the first series of 8 laryngeal
IMT, mostly described them as being unencapsulated3.
According to the most authors histological appearance is
characterized by spindle or stellate cells distributed in a
chronic inflammatory background and often displaying a
storiform, nodular or fascicular proliferation pattern.
The nuclei of these cells are rounded to oval and display a
low-grade pleomorphism within the range of a bona fide
benign lesion usually with a low mitotic rate (<2/10
HPF). The stroma can be myxoid, fibrillary or fibrous.
The inflammatory infiltrate is mainly mononuclear, con-
sisting of plasma cells with an admixture of lymphocytes,
histiocytes and eosinophils. If the overlying mucosa is
present, it can be ulcerated, inflamed or hyperplastic.
The blood vessels can be scarce or abundant. Immuno-
histochemically, the stromal cells are usually positive for
vimentin, SMA and muscle-specific actin2,3,17. The spec-
trum of morphologic appearance, giving base to the spec-
trum of synonyms, ranges from lesions composed almost
exclusively of plasma cells permeating fibroblastic/myo-
fibroblastic stroma to inflammatory infiltrate devoid le-
sions composed only of myofibroblasts and named myo-
fibroblastomas19. Others include in this spectrum the
inflammatory fibrosarcoma20 and inflammatory leiomyo-
sarcoma17. Differential diagnosis also includes inflamma-
tory soft tissue neoplasms which supposedly follow a
more aggressive course with recurrence and metastasis.
In biopsy material including only superficial parts of an
ulcerated lesion, the differentiation toward ulcerated
spindle cell carcinoma can arise. One should also rule out
lesions such as leiomyomas, solitary fibrous tumor, nodu-
lar fasciitis and peripheral nerve sheet tumor21. Because
of all that, detailed histological and immunohistochemical
analysis, preferably using vimentin, actin and CD68 is
obligatory, but unfortunately not always helpful and
without prognostic significance14.
The therapeutic approach of choice is a complete local
excision, possibly followed by postoperative steroid appli-
cation. Our patient had tumor recurrence after micro-
laser ablative surgery, although there are reports of ex-
cellent outcomes after partial laser vaporization6. Radia-
tion therapy can be successful in recurrent disease. Ste-
roid or radiation therapy as sole treatment seems not to
be quite effective17. Frequent follow-up with fiberoptic
laryngoscopy and CT scans are recommended to search
for recurrence.
Conclusion
The IMT of the larynx are usually of benign biological
behaviour and their recognition and proper diagnosis is
important in order to avoid unnecessary aggressive
treatment. However, the most effective treatment is total
excision. Even more, this diagnosis should alert clini-
cians to close follow-up of these patients.
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Fig. 1. Microscopical presentation of inflammatory myofibrobla-
stic tumor. Tumor cells presented mainly as spindle-shaped cells
with long to plump nuclei of fibroblastic appearance displaying
slight polymorphism (a), and in granulation tissue pleomorphic
endothelial cells were present (b). Immunohistochemically smooth
muscle actin positivity was present in majority of the fibroblastic
cells (c), while epitheloid and pleomorphic cells displayed CD31
positivity (d). (A and B, hemalaun and eosin stain, C and D im-
munohistochemistry).
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INFLAMATORNI MIOFIBROBLASTI^NI TUMOR LARINKSA: PRIKAZ SLU^AJA
S A @ E T A K
Inflamatorni miofibroblasti~ni tumor (IMT) je pseudosarkomatozna lezija mekih tkiva i solidnih organa. Poznat je
pod brojnim nazivima kao {to su inflamatorni pseudotumor, plazmastani~ni granulom ili pseudosarkomatozna miofi-
broblasti~na proliferacija. IMT se naj~e{}e nalazi u plu}ima, a izuzetno je rijedak u larinksu. Zbog svog biolo{kog pona-
{anja mo`e se pogre{no dijagnosticirati kao maligni tumor. Predstavljamo slu~aj IMT larinksa, koji je na vrijeme pre-
poznat i lije~en laserskom ablacijom. Ovaj slu~aj pokazuje va`nost prepoznavanja IMT kako bi se izbjeglo nepotrebno,
agresivno lije~enje, ali i nu`nost pra}enja ovakvih pacijenata.
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